Results 11 to 20 of about 207,392 (192)
Heterogeneity of mononuclear phagocytes in interstitial lung diseases [PDF]
, 1990 Interstitial lung diseases are a heterogeneous group of illnesses with different pathogeneses. In interstitial lung diseases there often is an increased influx of cells from the peripheral blood (PB) to the interstitium and alveoli.
Hoogsteden, H.C. (Henk)
core +12 more sources
BMC Pulmonary Medicine, 2021 Background Silicosis is a progressive pneumoconiosis characterized by interstitial fibrosis following exposure to silica dust. The role of metabolic dysregulation in the pathogenesis of silicosis has not been investigated in detail.
Changjiang Xue +4 more
doaj +1 more source
Cluster features in fibrosing interstitial lung disease and associations with prognosis
BMC Pulmonary Medicine, 2023 Background Clustering is helpful in identifying subtypes in complex fibrosing interstitial lung disease (F-ILD) and associating them with prognosis at an early stage of the disease to improve treatment management.
Yuanying Wang +5 more
doaj +1 more source
Cells, 2021 Elevated Serum Amyloid A (SAA) levels have been found in several inflammatory diseases, including sarcoidosis. SAA is suggested to be involved in sarcoidosis pathogenesis by involvement in granuloma formation and maintenance.
Els Beijer +5 more
doaj +1 more source
BMC Pulmonary Medicine, 2023 Background Pulmonary fibrosis (PF) is caused by a heterogeneous group of diseases, with a high inter-individual variability in disease trajectory. Identifying disease progression in patients with PF has impact on clinical management decisions.
Gizal Nakshbandi +9 more
doaj +1 more source
Airway involvement in interstitial lung disease [PDF]
, 2006 PURPOSE OF REVIEW: After briefly discussing several ways to approach airway involvement in interstitial lung diseases - by diagnostic methodologies used to assess it, considering different topographical involvement, related to its presence in the diffuse
Robalo-Cordeiro, C
core +1 more source
Interstitial lung disease: course report [PDF]
Breathe, 2020 The @EuroRespSoc course on ILD https://bit.ly/32PtzfH.
Michael Kreuter, Vitalii Poberezhets
openaire +2 more sources
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review
European Respiratory Review, 2021 Over the past three decades, an increasing number of publications have reported the association between interstitial lung disease (ILD) and anti-neutrophil cytoplasmic antibody (ANCA) or ANCA-associated vasculitis (AAV). With this increased awareness, we
Suha Kadura, Ganesh Raghu
doaj +1 more source
Interstitial lung disease [PDF]
European Respiratory Review, 2013 This article reviews the most important articles published in interstitial lung disease, as reviewed during the Clinical Year in Review session at the 2012 annual European Respiratory Society Congress in Vienna, Austria.Since the recent international guidelines for the management of idiopathic pulmonary fibrosis (IPF), important new evidence is ...
openaire +4 more sources
Lung transplantation for interstitial lung disease [PDF]
European Respiratory Review, 2021 Lung transplantation (LTx) can be a life-extending treatment option for patients with advanced and/or progressive fibrotic interstitial lung disease (ILD), especially idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis, sarcoidosis and connective tissue disease-associated ILD.
Siddhartha G. Kapnadak, Ganesh Raghu
openaire +3 more sources